The Form 4 filing, which reports an insider's stock trades to the SEC, was filed on Nov. 12, 2026. The sales took place two days earlier, on Nov. 10.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-10 |
| Date of Latest Transaction | 2026-11-10 |
| Buy/Sell | sell |
| Transaction Count | 2 |
| Shares Transacted | 185,134 |
| Price | $35.84 |
| Total Transaction Value | $6,636,065.23 |
| Insider | |
| Ticker Symbol | PGNY |
| Company | Progyny, Inc. |
| Insider Name | Anevski Peter |
| Insider Title | CHIEF EXECUTIVE OFFICER |
| Sector - Industry | Healthcare - Healthcare Plans |
| Holdings | |
| Total Shares Owned After Transaction | 762,468 |
| Position Size Change | 19.54% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were sales of Progyny (PGNY) shares, reported with transaction code S. Peter Anevski, the company's chief executive officer, reported two sale transactions.
What was the average price of the transaction?
The average price was $35.84 per share, rounded to cents. This average covers the shares sold across both transactions. Separate prices for each sale are not available.
How did this transaction affect the insider's holdings?
He sold 185,134 shares and reported 762,468 shares owned afterward. The sales represented 19.54% of the shares he held before the sales.
What's the total transaction value?
The total value for both sales was $6,636,065.23 when rounded to cents. The value before rounding was $6,636,065.2255.
Are there any special circumstances around this transaction?
Yes. The filing carries a Rule 10b5-1 trading-plan reference. Such plans set trading instructions in advance. Footnote text was not available, so it is unclear which of the two sales the plan covered. The plan's adoption date and trading schedule are also unknown. This reference alone does not explain why the shares were sold.
For research purposes only; not investment advice.